Journal article
Antiplatelet Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention
Abstract
Purpose of reviewThe evidence for use of dual antiplatelet therapy (DAPT) for patients undergoing percutaneous coronary intervention (PCI) in the elective setting is relatively sparse and is based on data from more than two decades ago. We will review the evidence supporting the use of DAPT with focus on stable patients undergoing elective PCI, including the role of potent P2Y12 inhibitors, modified DAPT durations, and more recently, aspirin …
Authors
Alkhalil M; Džavík V; Bhatt DL; Mehran R; Mehta SR
Journal
Current Cardiology Reports, Vol. 24, No. 3, pp. 277–293
Publisher
Springer Nature
Publication Date
3 2022
DOI
10.1007/s11886-022-01645-0
ISSN
1523-3782